Clinical trial

Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma…

NCT00286832 · Copenhagen University Hospital at Herlev, Other · Completed

Key facts

NCT number NCT00286832
Title Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
Official title Evaluation of Response to Treatment Using 18F-FDG Positron Emission Tomography Imaging (PET) With Special Emphasize on the Prognostic Significance of Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
Lead sponsor Copenhagen University Hospital at Herlev, Other
Collaborators Nordic Lymphoma Group
Status Completed
Study type Observational
Conditions Diffuse Large-Cell Lymphoma
Intervention type Procedure
Interventions PET scan
Enrollment 100
Start date Aug 1, 2005
Primary completion Jan 1, 2011
Completion Jan 1, 2011
First posted Feb 6, 2006
Last update posted Jul 6, 2011
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies